Skip to main content

How to cure Covid19 through Medicinal Plants

 

Chinese Scientists find Extract from TCM Treat COVID

Chinese doctors have obtained a patent for their work using cepharanthine, a chemical derived from traditional Chinese herbal medicine, to combat SARS-CoV-2, which has had promising results.


A patent has been granted to Chinese doctors for their work in combating SARS-CoV-2 with cepharanthine, a substance derived from traditional Chinese herbal therapy, which has shown promising effects.

Tong said he tested the efficiency of the chemical to limit the SAR-CoV-2 with scientists from the Wuhan Institute of Virology's Shi Zhengli and China's top respiratory specialist Zhong Nanshan's teams.

According to information supplied to the Global Times by Tong, the inhibition rate of cepharanthine at low doses can still reach as high as 100%.

Cepharanthine is a substance derived from Chinese herbal medicine. Researchers discovered that it can stop SARS-CoV-2 from infecting target cells by preventing viral binding. According to Tong, it can also inhibit viruses like HIV, SARS, HBV, and Ebola, making it a possible broad-spectrum anti-virus medication.


The treatment has been used on cancer patients for 40 years to boost their white blood cell count. So it's safe, according to Tong.

In early 2020, the researchers discovered the compound's promise in treating COVID-19, according to Tong. His team received the patent on May 10 as a result of widespread flare-ups that raised public expectations for more effective treatments and vaccinations.

Many other Chinese enterprises and researchers are speeding up development in addition to Tong's team's study, as experts underlined that successful therapies are one of the fundamental criteria for China to safely restart internal and international exchanges.

As of Friday, there were 21 domestic COVID-19 medications in development, six of which had entered phase III clinical trials, according to industrial analysis.


One of the most targeted candidates is VV116, an oral anti-SARS-CoV-2 nucleoside candidate developed jointly by the Shanghai Institute of Materia Medica of the Chinese Academy of Sciences and the Wuhan Institute of Virology. According to some experts, mid-term results from the medicine's phase III clinical trials might be announced next week, and the drug could be licensed for emergency use in China by mid-June.

Keywords:

Chinese Traditional Medicines

Chinese Herbals 

Chinese Cultural medicines 

Chinese Historic medicines

Chinese Old method for diagnosis of diseases 

China famous medicines  

Labels:
Location: China

Comments

Post a Comment

Popular posts from this blog

Guangxi Minzu University

Guangxi University for Nationalities (GXUN), located by the picturesque Xiangsi Lake in Nanning, Guangxi Zhuang Autonomous Region, was founded in 1952 as a branch of the Central Institute for Nationalities, now known as Minzu University of China.  Initially named Guangxi Provincial Institute for Nationalities in 1953, it later became Guangxi Institute for Nationalities in 1958 and finally adopted its current name in 2006. Co-financed by the State Ethnic Affairs Commission of China and the People’s Government of Guangxi, GXUN is a key institution in the region, often visited by prominent leaders from China and ASEAN countries. The university spans three campuses, covering a total area of 3500 Mu, and comprises 26 colleges offering a wide range of academic disciplines. It provides 4 doctoral programs, 16 master’s programs of superordinate disciplines, 75 master’s programs of secondary disciplines, 11 professional master’s programs, and 77 full-time undergraduate programs.  With an enroll
Post a Comment
Read more

Undergraduate Scholarship in China

2024 GXU Top Discipline Scholarship   Language of Instruction: Chinese Duration of Scholarship: Major Studies: 4 years (5 years for Architecture and Animal Medicine) Preparatory Chinese Language Learning: 1 year. Students without an HSK Certificate (level 4 minimum) must attend preparatory Chinese language learning. Students must pass HSK 4 before beginning major studies. Scholarship Benefits: Free tuition, accommodation, and insurance Monthly stipend of RMB 500 Eligibility Requirements: Applicants must be in good health. Applicants must be non-Chinese citizens with at least 10 years of residence, study, or work experience in their home country. Applicants must respect Chinese laws and policies. Applicants must demonstrate good academic performance and behavior. Applicants must not hold other scholarships in China simultaneously. Application Timeline: Deadline: 15 July 2024 Application Process: Applicants must apply online through the university website (link provided below) before
Post a Comment
Read more

MaShan Mountain/ Horse Mountain Guangxi

Horse Mountain, under the jurisdiction of Nanning City, Guangxi Zhuang Autonomous Region, is located in the central and northern part of Guangxi Zhuang Autonomous Region, north of Nanning City, on the south bank of the middle reaches of the Hongshui River, and at the northern foot of the Daming Mountain. It lies between 107°42′38″E to 108°30′00″E longitude and 23°24′06″N to 24°02′06″N latitude. It borders Shanglin County and Xincheng County of Laibin City to the east, adjacent to Wuming District to the south, borders Pingguo City and Dahua Yao Autonomous County of Baise City to the west, and faces Du'an Yao Autonomous County of Hechi City across the Hongshui River to the north. The county is elongated from east to west and irregularly shaped, with a maximum east-west distance of 82 kilometers and a maximum north-south distance of 71 kilometers, totaling a boundary length of 412.27 kilometers with neighboring counties. The total area of Horse Mountain County is 2,340.76 square kil
Post a Comment
Read more